Treating Multiple Myeloma by Targeting the NF-Kappa-B Pathway with Gadd45-Beta/MKK7 Inhibitors

Laura B Freeman

Pooled Investigation of Pesticides and Lymphoma and Multiple Myeloma and Immunoproliferative Diseases in NCI and Cross-Canada Case-Control Studies

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

William Figg

Using Clinical Pharmacology Principles to Develop New Anticancer Therapies

Thymus Prostate Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Ruben D Carrasco

Validating the eCyPA/CD147 signaling complex for myeloma therapy

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Multiple Myeloma Study / Histological Classification and Clinical Course of Surface Epithelial Ovarian Tumors in Abuja

Ovary Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Daniel M Sullivan

CRM1 INHIBITORS SENSITIZE MULTIPLE MYELOMA CELLS TO TOPOISOMERASE II AND PROTEASOME INHIBITORS

Multiple myeloma and immunoproliferative diseases

Ratneshwar Lal

Amyloid ion channels to design therapeutics for neurodegenerative diseases

Multiple myeloma and immunoproliferative diseases

Pathology

Linda J Burns

Training and Mentorship of Hematologic Oncologists

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Nikhil C Munshi

Integrative Oncogenomics of Multiple Myeloma

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Jonathan Hofmann

Reproductive Factors and Risk of Multiple Myeloma and Immunoproliferative Diseases in the International Multiple Myeloma and Immunoproliferative Diseases Consortium

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology